Question：You are the auditor of Nenox, a large public limited pharmaceuticals manufacturer. The audit is complex and high profile and it is particularly important that non-sampling risk is minimised.
Which of the following would have no effect on non-sampling risk?
A. Review the audit working papers more frequently.
B. Produce a detailed planning memorandum.
C. Use more experienced staff.
D. Increase the number of items selected for detailed testing.
The correct answer is:Increase the number of items selected for detailed testing.
解析：Increasing the number of items selected for detailed testing will impact on sampling risk but will have no effect on non-sampling risk.
The other three choices will have the effect of reducing non-sampling risk.
　　高顿网校温馨提醒
　　各位考生，2016年ACCA备考已经开始，为了方便各位学员能更加系统地掌握考试大纲的重点知识，帮助大家充分备考，体验实战，高顿网校开通了全免费的ACCA题库（包括精题真题和全真模考系统），题库里附有详细的答案解析，学员可以通过多种题型加强练习。戳这里进入ACCA免费题库>>>

微信扫一扫，关注ACCA*7资讯，满满的干货喂饱你！ACCA微信公众号：gaodunaccaACCA分享与交流QQ群：227573128 

展开全文